AndrewRobertStiffMD

PubMed

• Correction: HDAC inhibitor AR-42 decreases CD44 expression and sensitizes myeloma cells to lenalidomide.
  Alessandro Canella, Hector Cordero Nieves, Douglas W Sborov, Luciano Cascione, Hanna S Radomska, Emily Smith, Andrew Stiff, Jessica Consiglio, Enrico Caserta, Lara Riz...> ;Oncotarget. 2023 Sep 25
• 3 citations
  Myeloid-Derived Suppressor Cells: New Insights into the Pathogenesis and Therapy of MDS.
  Maria Velegraki, Andrew Stiff, Helen A Papadaki, Zihai Li> ;Journal of Clinical Medicine. 2022 Aug 21
• 1 citations
  A solitary brain metastasis as the only site of recurrence of HR positive, HER2 negative breast cancer: a case report and review of the literature
  Sandipkumar H. Patel, Yoshihito David Saito, Zaibo Li, Bhuvaneswari Ramaswamy, Andrew Stiff, Mahmoud Kassem, Robert Wesolowski> ;Journal of Medical Case Reports. 2021 Jan 7
• 12 citations
  Exploratory analysis of immune checkpoint receptor expression by circulating T cells and tumor specimens in patients receiving neo-adjuvant chemotherapy for operable b...
  Robert Wesolowski, Andrew Stiff, Dionisia Quiroga, Christopher McQuinn, Zaibo Li, Hiroaki Nitta, Himanshu Savardekar, Brooke Benner, Bhuvaneswari Ramaswamy, Maryam B. ...> ;BMC Cancer. 2020 May 19
• 5 citations
  Neuroblastoma RAS viral oncogene homolog mRNA is differentially spliced to give five distinct isoforms: implications for melanoma therapy.
  Megan C. Duggan, Kelly Regan-Fendt, Gonzalo N. Olaverria Salavaggione, John Harrison Howard, Andrew Stiff, Julia Sabella, Nicholas Latchana, Joseph Markowitz, Alejandr...> ;Melanoma Research. 2019 Oct 1
• 13 citations
  Evidence for interaction of the NLRP3 inflammasome and Bruton's tyrosine kinase in tumor-associated macrophages: implications for myeloid cell production of interleuki...
  Brooke Benner, Luke Scarberry, Andrew Stiff, Megan C. Duggan, Logan Good, Gabriella Lapurga, Jonathan P. Butchar, Susheela Tridandapani, William E. Carson> ;Oncoimmunology. 2019 Sep 5
• 51 citations
  Modeling combination therapy for breast cancer with BET and immune checkpoint inhibitors
  Xiulan Lai, Andrew Stiff, Megan C. Duggan, Robert Wesolowski, William E. Carson, Avner Friedman> ;Proceedings of the National Academy of Sciences of the United States of America. 2018 May 22
• 2 citations
  Author Correction: Nitric oxide mediated inhibition of antigen presentation from DCs to CD4+ T cells in cancer and measurement of STAT1 nitration.
  Joseph Markowitz, Jiang Wang, Zach Vangundy, Jia You, Vedat O. Yildiz, Lianbo Yu, Isaac P. Foote, Owen E. Branson, Andrew Stiff, Taylor R. Brooks, Brandon J. Biesiadec...> ;Scientific Reports. 2018 Mar 6
• 57 citations
  Nitric oxide mediated inhibition of antigen presentation from DCs to CD4 + T cells in cancer and measurement of STAT1 nitration
  Joseph Markowitz, Jiang Wang, Zach Vangundy, Jia You, Vedat O. Yildiz, Lianbo Yu, Isaac P. Foote, Owen E. Branson, Andrew Stiff, Taylor R. Brooks, Brandon J. Biesiadec...> ;Scientific Reports. 2017 Nov 13
• 50 citations
  Circulating myeloid-derived suppressor cells increase in patients undergoing neo-adjuvant chemotherapy for breast cancer
  Robert Wesolowski, Megan C. Duggan, Andrew Stiff, Joseph Markowitz, Prashant Trikha, Kala M. Levine, Lynn Schoenfield, Mahmoud Abdel-Rasoul, Rachel M. Layman, Bhuvanes...> ;Cancer Immunology, Immunotherapy. 2017 Jul 7
• 17 citations
  Identification of NRAS isoform 2 overexpression as a mechanism facilitating BRAF inhibitor resistance in malignant melanoma.
  Megan C. Duggan, Andrew Stiff, Maryam Bainazar, Kelly Regan, Gonzalo N. Olaverria Salavaggione, Sophia E. Maharry, James S. Blachly, Christopher J. Walker, Nicholas La...> ;Proceedings of the National Academy of Sciences of the United States of America. 2017 Aug 21
• 143 citations
  Nitric Oxide Production by Myeloid-Derived Suppressor Cells Plays a Role in Impairing Fc Receptor-Mediated Natural Killer Cell Function.
  Andrew Stiff, Prashant Trikha, Bethany L. Mundy-Bosse, Elizabeth L. McMichael, Thomas A. Mace, Brooke Benner, Kari Kendra, Amanda Campbell, Shalini Gautam, David Abood...> ;Clinical Cancer Research. 2018 Apr 15
• 10 citations
  The combination of MLN2238 (ixazomib) with interferon-alpha results in enhanced cell death in melanoma.
  Lorena P. Suarez-Kelly, Gregory M. Kemper, Megan C. Duggan, Andrew Stiff, Tiffany Noel, Joseph Markowitz, Eric Luedke, Vedat O. Yildiz, Lianbo Yu, Alena Cristina Jaime...> ;Oncotarget. 2016 Oct 21
• 22 citations
  Targeting myeloid-derived suppressor cells using a novel adenosine monophosphate-activated protein kinase (AMPK) activator
  Prashant Trikha, Robert L. Plews, Andrew Stiff, Shalini Gautam, Vincent Hsu, David Abood, Robert Wesolowski, Ian Landi, Xiaokui Mo, John E. Phay, Ching-Shih Chen, John...> ;Oncoimmunology. 2016 Jul 25
• 5 citations
  Structural characterization of NRAS isoform 5
  Joseph Markowitz, Tapas K. Mal, Chunhua Yuan, Nicholas B. Courtney, Mitra Patel, Andrew Stiff, James S. Blachly, Christopher J. Walker, Ann-Kathrin Eisfeld, Albert de ...> ;Protein Science. 2016 May 1
• 134 citations
  Myeloid-derived suppressor cells express Bruton's tyrosine kinase and can be depleted in tumor bearing hosts by ibrutinib treatment
  Andrew Stiff, Prashant Trikha, Robert Wesolowski, Kari Kendra, Vincent Hsu, Sarvani Uppati, Elizabeth L. McMichael, Megan C. Duggan, Amanda Campbell, Karen A. Keller, ...> ;Cancer Research. 2016 Feb 15
• 55 citations
  Analysis of the Effects of the Bruton's tyrosine kinase (Btk) Inhibitor Ibrutinib on Monocyte Fcγ Receptor (FcγR) Function.
  Li Ren, Amanda Campbell, Huiqing Fang, Shalini Gautam, Saranya Elavazhagan, Kavin Fatehchand, Payal Mehta, Andrew Stiff, Brenda F. Reader, Xiaokui Mo, John C. Byrd, Wi...> ;The Journal of Biological Chemistry. 2016 Feb 5
• 31 citations
  Histone Deacetylase Inhibitors Enhance the Therapeutic Potential of Reovirus in Multiple Myeloma
  Andrew Stiff, Enrico Caserta, Douglas W. Sborov, Gerard J. Nuovo, Xiaokui Mo, Sarah Schlotter, Alessandro Canella, Emily Smith, Joseph Badway, Matthew O. Old, Alena Cr...> ;Molecular Cancer Therapeutics. 2016 Jan 25
• 13 citations
  Gene expression profiling of the human natural killer cell response to Fc receptor activation: unique enhancement in the presence of interleukin-12.
  Amanda Campbell, Kelly Regan, Neela Bhave, Arka Pattanayak, Robin Parihar, Andrew Stiff, Prashant Trikha, Steven D. Scoville, Sandya Liyanarachchi, Sri Vidya Kondadasu...> ;BMC Medical Genomics. 2015 Oct 15
• 36 citations
  HDAC inhibitor AR-42 decreases CD44 expression and sensitizes myeloma cells to lenalidomide
  Alessandro Canella, Hector Cordero Nieves, Douglas W. Sborov, Luciano Cascione, Hanna S. Radomska, Emily Smith, Andrew Stiff, Jessica Consiglio, Enrico Caserta, Lara R...> ;Oncotarget. 2015 Sep 28
• 29 citations
  Investigations of interferon-lambda for the treatment of cancer.
  Andrew Stiff, William E. Carson> ;Journal of Innate Immunity. 2015 Feb 6
• 61 citations
  A Phase I Trial of Single-Agent Reolysin in Patients with Relapsed Multiple Myeloma
  Douglas W. Sborov, Gerard J. Nuovo, Andrew Stiff, Thomas A. Mace, Gregory B. Lesinski, Don M. Benson, Yvonne A. Efebera, Ashley E. Rosko, Flavia Pichiorri, Michael R. ...> ;Clinical Cancer Research. 2014 Dec 1
• 48 citations
  Circulating miRNA markers show promise as new prognosticators for multiple myeloma.
  Alberto Rocci, Craig C. Hofmeister, Susan Geyer, Andrew Stiff, Manuela Gambella, Luciano Cascione, Jingwen Guan, Don M. Benson, Yvonne A. Efebera, Tiffany Talabere, Vi...> ;Leukemia. 2014 May 12
• Join now to see all

Journal Articles

• Modeling Combination Therapy for Breast Cancer with BET and Immune Checkpoint Inhibitors  
  Robert Wesolowski, Andrew Stiff, Proceedings of the National Academy of Sciences